Yahoo! Finance: SRDX News

SURMODICS INC Financials (EDGAR Online Financials)

Fri, 18 Dec 2009 18:04:27 Etc/GMT

Prospecting for Stocks: Becton, Dickinson and Co. (at Motley Fool)

Mon, 14 Dec 2009 17:42:47 Etc/GMT

SURMODICS INC Files SEC form 10-K, Annual Report (EDGAR Online)

Fri, 11 Dec 2009 22:29:09 Etc/GMT

SURMODICS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statemen (EDGAR Online)

Fri, 4 Dec 2009 20:09:57 Etc/GMT

OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent (PR Newswire)

Tue, 1 Dec 2009 16:32:00 Etc/GMT

OrbusNeich today announced the initiation of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent .

Piper Jaffray Senior Research Analyst Sees M&A Activity As Brisk As Foreign Companies Seek US Specialty Pharmaceutical Distribution Networks (Wall Street Transcript)

Fri, 13 Nov 2009 13:57:00 Etc/GMT

67 WALL STREET, New York - November 13, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

How to Navigate the Raging Bull: Friday's PowerRatings 3 Pack (TradingMarkets.com)

Fri, 6 Nov 2009 15:04:26 Etc/GMT

Looking to locate stocks that are most likely to attract the bargain hunting crowd during bull markets? Here are 3 names fitting this criteria.

SurModics Misses (Zacks.com)

Thu, 5 Nov 2009 17:03:09 Etc/GMT

SurModics' fourth-quarter earnings per share came in at 18 cents, below the Zacks Consensus Estimate of 20 cents.

New Star Analyst Rankings for SurModics, Inc. (StarMine)

Thu, 5 Nov 2009 14:29:23 Etc/GMT

SurModics, Inc.Q4 2009 Earnings Call Transcript (at Seeking Alpha)

Thu, 5 Nov 2009 01:29:07 Etc/GMT

SurModics, Inc. Earnings Call scheduled for 5:00 pm ET today (CCBN)

Wed, 4 Nov 2009 22:00:00 Etc/GMT

SURMODICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)

Wed, 4 Nov 2009 21:13:32 Etc/GMT

SurModics Reports Fourth Quarter and Fiscal Year 2009 Results (Business Wire)

Wed, 4 Nov 2009 21:01:00 Etc/GMT

EDEN PRAIRIE, Minn.----SurModics, Inc. , a leading provider of drug delivery and surface modification technologies to the healthcare industry, today reported financial results for the fourth quarter and fiscal year ended September 30, 2009.

Q4 2009 SurModics, Inc. Earnings Release - After Market Close (CCBN)

Wed, 4 Nov 2009 12:07:25 Etc/GMT

SurModics and NuPathe Partner to Develop Novel Long-Acting Parkinson's Treatment (Business Wire)

Mon, 2 Nov 2009 21:31:00 Etc/GMT

EDEN PRAIRIE, Minn. & CONSHOHOCKEN, Pa.----SurModics, Inc. , a leading provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced today that the companies have entered into a license agreement for drug delivery technology.

SurModics to Webcast Fourth Quarter and Fiscal Year 2009 Earnings Conference Call November 4 (Business Wire)

Wed, 28 Oct 2009 20:00:00 Etc/GMT

EDEN PRAIRIE, Minn.----SurModics, Inc. , a leading provider of drug delivery and surface modification technologies to the healthcare industry, announced today that it will host a live webcast of its fourth quarter and fiscal year 2009 conference call on Wednesday, November 4, at 4:00 p.m.

SurModics downgraded by Barrington Research (Briefing.com)

Tue, 13 Oct 2009 12:44:37 Etc/GMT

SURMODICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (EDGAR Online)

Fri, 9 Oct 2009 18:09:13 Etc/GMT

Genentech inks licensing deal with SurModics (at bizjournals.com)

Wed, 7 Oct 2009 17:05:22 Etc/GMT

SurModics inks $200M licensing deal with Genentech (at bizjournals.com)

Tue, 6 Oct 2009 17:05:27 Etc/GMT